JP Stock MarketDetailed Quotes

4331 Take And Give Needs

Watchlist

954
+12+1.27%

20min DelayMarket Closed Dec 30 15:30 JST

13.95BMarket Cap9.26P/E (Static)

Take And Give Needs Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Mar 31, 2024

(Q4)Mar 31, 2024

(Q3)Dec 31, 2023

(Q2)Sep 30, 2023

(Q1)Jun 30, 2023

(FY)Mar 31, 2023

(Q4)Mar 31, 2023

(Q3)Dec 31, 2022

(Q2)Sep 30, 2022

(Q1)Jun 30, 2022

Total revenue

3.27%47.02B

20.30%11.75B

3.39%13.61B

-4.65%10.57B

-3.68%11.09B

15.32%45.53B

-0.67%9.77B

13.03%13.17B

30.03%11.09B

21.50%11.51B

Cost of revenue

-0.81%15.71B

15.12%3.88B

0.09%4.54B

-8.28%3.57B

-7.94%3.72B

15.23%15.84B

-1.72%3.37B

14.98%4.54B

29.42%3.89B

20.15%4.04B

Gross profit

5.45%31.31B

23.06%7.87B

5.12%9.07B

-2.69%7.01B

-1.39%7.37B

15.37%29.69B

-0.13%6.39B

12.05%8.63B

30.33%7.2B

22.26%7.47B

Operating expense

4.19%27.1B

-3.56%7.64B

4.67%6.5B

9.10%6.55B

9.12%6.42B

10.00%26.01B

30.26%7.92B

6.86%6.21B

4.40%6B

-2.10%5.88B

Operating profit

14.34%4.21B

115.15%231M

6.29%2.57B

-61.67%460M

-40.25%950M

76.12%3.68B

-573.60%-1.53B

28.03%2.42B

638.12%1.2B

1,428.85%1.59B

Net non-operating interest income (expenses)

-14.45%-491M

-19.81%-127M

-13.76%-124M

-12.96%-122M

-11.32%-118M

-8.33%-429M

-1.92%-106M

-10.10%-109M

-14.89%-108M

-7.07%-106M

Non-operating interest income

--0

0.00%1M

--0

--1M

--0

Non-operating interest expense

14.19%491M

19.81%127M

12.73%124M

12.96%122M

11.32%118M

8.31%430M

1.92%106M

11.11%110M

13.68%108M

7.07%106M

Net investment income

Gain(Loss) on financial instruments designated as cash flow hedges

Gain(Loss) on derecognition of available-for-sale financial assets

62M

Income from associates and other participating interests

Special income (charges)

-26.21%-520M

55.82%-349M

-13,000.00%-129M

-116.80%-42M

-249.82%-412M

39.97%-790M

-99.89%1M

-52.08%127M

-43.69%250M

Less:Other special charges

96.59%-10M

----

85.05%-293M

121.14%85M

99.89%-1M

47.08%-127M

42.79%-250M

Less:Write off

-24.82%530M

-49.08%359M

--129M

--0

--42M

-58.16%705M

-58.96%705M

--0

Other non-operating income (expenses)

132.89%25M

135.14%26M

-500.00%-42M

0.00%3M

1,800.00%38M

39.68%-76M

-1,580.00%-74M

80.56%-7M

0.00%3M

102.04%2M

Income before tax

18.89%3.29B

93.75%-156M

-1.22%2.27B

-71.93%343M

-52.42%826M

50.05%2.76B

-127.23%-2.5B

-12.74%2.3B

2,593.88%1.22B

393.18%1.74B

Income tax

208.26%1.46B

121.09%163M

33.74%868M

-74.45%104M

119.67%320M

-3,740.00%-1.34B

-168.40%-773M

64.30%649M

466.67%407M

-5,148.39%-1.63B

Net income

-55.43%1.83B

81.48%-319M

-14.89%1.41B

-70.67%239M

-84.98%505M

118.86%4.11B

-112.86%-1.72B

-26.28%1.65B

1,214.52%815M

778.07%3.36B

Net income continuous operations

-55.43%1.83B

81.48%-319M

-14.95%1.41B

-70.67%239M

-84.95%506M

118.86%4.11B

-112.59%-1.72B

-26.32%1.65B

1,214.52%815M

778.07%3.36B

Noncontrolling interests

Net income attributable to the company

-55.43%1.83B

81.48%-319M

-14.89%1.41B

-70.67%239M

-84.98%505M

118.86%4.11B

-112.86%-1.72B

-26.28%1.65B

1,214.52%815M

778.07%3.36B

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

-55.43%1.83B

81.48%-319M

-14.89%1.41B

-70.67%239M

-84.98%505M

118.86%4.11B

-112.86%-1.72B

-26.28%1.65B

1,214.52%815M

778.07%3.36B

Gross dividend payment

Basic earnings per share

-62.23%113.59

81.77%-24.92

-24.25%93.41

-77.31%13.34

-87.56%31.76

133.35%300.77

-105.94%-136.68

-26.98%123.31

7,247.50%58.78

897.50%255.36

Diluted earnings per share

-55.43%103.07

81.77%-24.92

-35.85%79.1

-77.31%13.34

-84.94%28.52

118.75%231.26

-105.94%-136.68

-26.98%123.31

7,247.50%58.78

777.17%189.38

Dividend per share

0.00%20

-50.00%10

Currency Unit

JPY

Accounting Standards

NonUS-GAAP

	(FY)Mar 31, 2024	(Q4)Mar 31, 2024	(Q3)Dec 31, 2023	(Q2)Sep 30, 2023	(Q1)Jun 30, 2023	(FY)Mar 31, 2023	(Q4)Mar 31, 2023	(Q3)Dec 31, 2022	(Q2)Sep 30, 2022	(Q1)Jun 30, 2022
Total revenue	3.27%47.02B	20.30%11.75B	3.39%13.61B	-4.65%10.57B	-3.68%11.09B	15.32%45.53B	-0.67%9.77B	13.03%13.17B	30.03%11.09B	21.50%11.51B
Cost of revenue	-0.81%15.71B	15.12%3.88B	0.09%4.54B	-8.28%3.57B	-7.94%3.72B	15.23%15.84B	-1.72%3.37B	14.98%4.54B	29.42%3.89B	20.15%4.04B
Gross profit	5.45%31.31B	23.06%7.87B	5.12%9.07B	-2.69%7.01B	-1.39%7.37B	15.37%29.69B	-0.13%6.39B	12.05%8.63B	30.33%7.2B	22.26%7.47B
Operating expense	4.19%27.1B	-3.56%7.64B	4.67%6.5B	9.10%6.55B	9.12%6.42B	10.00%26.01B	30.26%7.92B	6.86%6.21B	4.40%6B	-2.10%5.88B
Operating profit	14.34%4.21B	115.15%231M	6.29%2.57B	-61.67%460M	-40.25%950M	76.12%3.68B	-573.60%-1.53B	28.03%2.42B	638.12%1.2B	1,428.85%1.59B
Net non-operating interest income (expenses)	-14.45%-491M	-19.81%-127M	-13.76%-124M	-12.96%-122M	-11.32%-118M	-8.33%-429M	-1.92%-106M	-10.10%-109M	-14.89%-108M	-7.07%-106M
Non-operating interest income	--0	--0	--0	--0	--0	0.00%1M	--0	--1M	--0	--0
Non-operating interest expense	14.19%491M	19.81%127M	12.73%124M	12.96%122M	11.32%118M	8.31%430M	1.92%106M	11.11%110M	13.68%108M	7.07%106M
Net investment income
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets	62M					0
Income from associates and other participating interests
Special income (charges)	-26.21%-520M	55.82%-349M	-13,000.00%-129M	0	-116.80%-42M	-249.82%-412M	39.97%-790M	-99.89%1M	-52.08%127M	-43.69%250M
Less:Other special charges	96.59%-10M	----	----	----	----	85.05%-293M	121.14%85M	99.89%-1M	47.08%-127M	42.79%-250M
Less:Write off	-24.82%530M	-49.08%359M	--129M	--0	--42M	-58.16%705M	-58.96%705M	--0	--0	--0
Other non-operating income (expenses)	132.89%25M	135.14%26M	-500.00%-42M	0.00%3M	1,800.00%38M	39.68%-76M	-1,580.00%-74M	80.56%-7M	0.00%3M	102.04%2M
Income before tax	18.89%3.29B	93.75%-156M	-1.22%2.27B	-71.93%343M	-52.42%826M	50.05%2.76B	-127.23%-2.5B	-12.74%2.3B	2,593.88%1.22B	393.18%1.74B
Income tax	208.26%1.46B	121.09%163M	33.74%868M	-74.45%104M	119.67%320M	-3,740.00%-1.34B	-168.40%-773M	64.30%649M	466.67%407M	-5,148.39%-1.63B
Net income	-55.43%1.83B	81.48%-319M	-14.89%1.41B	-70.67%239M	-84.98%505M	118.86%4.11B	-112.86%-1.72B	-26.28%1.65B	1,214.52%815M	778.07%3.36B
Net income continuous operations	-55.43%1.83B	81.48%-319M	-14.95%1.41B	-70.67%239M	-84.95%506M	118.86%4.11B	-112.59%-1.72B	-26.32%1.65B	1,214.52%815M	778.07%3.36B
Noncontrolling interests
Net income attributable to the company	-55.43%1.83B	81.48%-319M	-14.89%1.41B	-70.67%239M	-84.98%505M	118.86%4.11B	-112.86%-1.72B	-26.28%1.65B	1,214.52%815M	778.07%3.36B
Preferred stock dividends
Other under preferred stock dividend	0	0	0	0	0	0	0	0	0	0
Net income attributable to common stockholders	-55.43%1.83B	81.48%-319M	-14.89%1.41B	-70.67%239M	-84.98%505M	118.86%4.11B	-112.86%-1.72B	-26.28%1.65B	1,214.52%815M	778.07%3.36B
Gross dividend payment
Basic earnings per share	-62.23%113.59	81.77%-24.92	-24.25%93.41	-77.31%13.34	-87.56%31.76	133.35%300.77	-105.94%-136.68	-26.98%123.31	7,247.50%58.78	897.50%255.36
Diluted earnings per share	-55.43%103.07	81.77%-24.92	-35.85%79.1	-77.31%13.34	-84.94%28.52	118.75%231.26	-105.94%-136.68	-26.98%123.31	7,247.50%58.78	777.17%189.38
Dividend per share	0.00%20	-50.00%10	0	10	0	20	20	0	0	0
Currency Unit	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY
Accounting Standards	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP

Symbol Price % Chg

D. Western Therapeutics Institute

4576

201 +23.31%

See the daily top gainer.